Cellectar Biosciences received a Zacks Rank #2 upgrade reflecting an upward trend in its earnings estimates.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cellectar Biosciences received a Zacks Rank #2 upgrade reflecting an upward trend in its earnings estimates.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cellectar Biosciences (United States)
company in Madison, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksAll You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy Cellectar Biosciences, Inc. (CLRB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #